Home » Topics » Regulatory

Regulatory
RSS

Apligraf PMA supplement tentatively scheduled for FDA review in May

April 11, 2000

New formulation of Hectorol approved by FDA

April 11, 2000

Bayer obtains first approval worldwide for new antiallergic agent

April 11, 2000

FDA gives go-ahead for Access to commence OraDisc clinical trials

April 5, 2000

Another indication for Enbrel will be discussed at advisory committee meeting

April 5, 2000

CollaGenex seeks FDA approval for new dosage form of Periostat

April 5, 2000

Avandia receives FDA approval for treatment of type II diabetes in combination with sulfonylureas

April 4, 2000

SmithKline Beecham claims 5-HT6 antagonists for ADHD

March 30, 2000

Organogenesis receives milestone payment related to Apligraf progress

March 30, 2000

Merck & Co. confirms study results of Singulair as allergic rhinitis treatment

March 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.